EMVision Medical Devices Ltd (EMV.AX)
AUD 1.89
(-0.53%)
AUD 1.89
(-0.53%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.72 Million AUD | 29.48% |
| 2023 | -3.87 Million AUD | 36.64% |
| 2022 | -6.1 Million AUD | 27.26% |
| 2021 | -8.39 Million AUD | -141.64% |
| 2020 | -3.47 Million AUD | -17.45% |
| 2019 | -2.95 Million AUD | -250.2% |
| 2018 | -845.04 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -2.61 Million AUD | 0.0% |
| 2024 FY | -2.72 Million AUD | 29.48% |
| 2024 Q2 | -112.6 Thousand AUD | 0.0% |
| 2023 Q2 | -758.5 Thousand AUD | 0.0% |
| 2023 FY | -3.87 Million AUD | 36.64% |
| 2023 Q4 | -3.11 Million AUD | 0.0% |
| 2022 FY | -6.1 Million AUD | 27.26% |
| 2022 Q2 | -2.02 Million AUD | 0.0% |
| 2022 Q4 | -4.07 Million AUD | 0.0% |
| 2021 Q2 | -3.21 Million AUD | 0.0% |
| 2021 FY | -8.39 Million AUD | -141.64% |
| 2021 Q4 | -5.18 Million AUD | 0.0% |
| 2020 FY | -3.47 Million AUD | -17.45% |
| 2020 Q4 | -1.67 Million AUD | 0.0% |
| 2020 Q2 | -1.8 Million AUD | 0.0% |
| 2019 Q4 | -1.32 Million AUD | -79.18% |
| 2019 Q3 | -739.84 Thousand AUD | 54.71% |
| 2019 Q2 | -1.63 Million AUD | 0.0% |
| 2019 FY | -2.95 Million AUD | -250.2% |
| 2018 Q2 | -312.44 Thousand AUD | -100.0% |
| 2018 FY | -845.04 Thousand AUD | 0.0% |
| 2018 Q1 | -156.22 Thousand AUD | 0.0% |
| 2018 Q4 | -532.59 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 92.413% |
| Adherium Limited | -10.22 Million AUD | 73.302% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 71.999% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 60.139% |
| Anteris Technologies Ltd | -67.33 Million AUD | 95.946% |
| Control Bionics Limited | -5.91 Million AUD | 53.843% |
| CardieX Limited | -6.76 Million AUD | 59.653% |
| Compumedics Limited | -338 Thousand AUD | -707.577% |
| Cochlear Limited | 356.8 Million AUD | 100.765% |
| CleanSpace Holdings Limited | -3.12 Million AUD | 12.712% |
| Cyclopharm Limited | -4.7 Million AUD | 41.933% |
| Nova Eye Medical Limited | -8.79 Million AUD | 68.946% |
| HeraMED Limited | -6.78 Million AUD | 59.762% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 87.936% |
| ImpediMed Limited | -19.79 Million AUD | 86.207% |
| InhaleRx Limited | -1.44 Million AUD | -89.127% |
| LBT Innovations Limited | -3.74 Million AUD | 27.016% |
| Micro-X Limited | -9.76 Million AUD | 72.047% |
| Neurotech International Limited | -5.06 Million AUD | 46.154% |
| OncoSil Medical Limited | -11.91 Million AUD | 77.088% |
| PolyNovo Limited | 5.26 Million AUD | 151.884% |
| Respiri Limited | -7.12 Million AUD | 61.713% |
| SomnoMed Limited | -12.24 Million AUD | 77.702% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 59.511% |
| Uscom Limited | -2.07 Million AUD | -31.563% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | 46.09% |